Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes... Show more
LNTH is expected to report earnings to fall 17.42% to $1.28 per share on October 29
Q3'26
Est.
$1.28
Q2'26
Beat
by $0.26
Q1'26
Beat
by $0.23
Q4'25
Beat
by $0.51
Q3'25
Missed
by $0.01
The last earnings report on August 06 showed earnings per share of $1.55, beating the estimate of $1.29. With 598.09K shares outstanding, the current market capitalization sits at 6.56B.